Vicente Valero

Dr. Vicente Valero is a Professor and Deputy Chairman in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center. He has been affiliated with MD Anderson since 1991, with expertise in breast cancer, particularly inflammatory breast cancer (IBC) and HER2-positive cancers. His academic credentials include an M.D. from Universidad Autonoma de Nuevo Leon, followed by postgraduate training in Internal Medicine at St. Elizabeth Hospital and Northeastern Ohio University College of Medicine, and fellowships in Hematology-Medical Oncology at the University of Cincinnati and The University of Texas Medical Branch in Galveston. Board-certified in Internal Medicine, Medical Oncology, and Hematology, Dr. Valero is a leading researcher in neoadjuvant therapies, molecular residual disease, and IBC treatment protocols.

His research focuses on improving outcomes for metastatic breast cancer patients, optimizing surgical de-escalation strategies, and advancing immunotherapy and targeted therapies. He leads multiple clinical trials, including NRG-BR004 and NRG-BR003, and has authored over 150 peer-reviewed articles. Dr. Valero is recognized for his dedication to education, having received the Division of Medicine Teacher of the Year award twice and the Educator of the Month honor. He actively contributes to multidisciplinary quality assurance conferences and serves as a primary investigator for several funded research protocols.

Key achievements include developing the R-IBC residual tumor burden calculator and pioneering studies on eliminating breast surgery for exceptional responders to systemic therapy. His work emphasizes translating research into clinical practice to enhance early detection, prevention, and treatment efficacy in breast cancer.